Skip to main content

2019 | OriginalPaper | Buchkapitel

Precision Medicine: A Personalized Treatment from Your Gene

verfasst von : P. K. Balasubramani, K. Preetha, M. Aswanth Harish

Erschienen in: Proceedings of the International Conference on Nanomedicine (ICON-2019)

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Poor healthcare linked to 5 million annual death worldwide. Health is increasingly shaped by ageing populations, urbanization and globalization of unhealthy lifestyles, resulting in a transition in the burden of health care towards non communicable diseases, mental health and injuries. Many of these conditions are chronic, requiring long-term care, with patients commonly suffering from multi-morbidities, all of which adds to escalating health care costs. Precision medicine (PM) is a new approach to health care that matches individual patients with targeted treatments that work best for each them. PM is still in its infancy, but holds so much promise for the healthcare industry which considers genetic variations, environment and lifestyle. There would be global shift in the treatment modalities where people are moving towards pharmacogenomics which takes into consideration of the individual drug response to how body metabolize it helping in catering the patients with minimal Adverse Drug Reaction (ADR). Another field which is showing promise in the healthcare industry is wearable bio-services for better health and disease management. PM has roadblocks to clear before it hits the market clinician acceptability, pharma industry to cater drug to small population, developing diagnostic tests with sufficient sensitivity and specificity and having string regulatory mechanism to ensure clinical validity to the tests.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Kalaitzopoulos, D.: The potential of precision medicine. New Horizons Transl. Med. 3, 63–65 (2016) Kalaitzopoulos, D.: The potential of precision medicine. New Horizons Transl. Med. 3, 63–65 (2016)
2.
Zurück zum Zitat Kwon, H., Jung, E.-Y.: The impact of policy on the growth of precision medicine. Healthy Policy Technol. 7, 347–357 (2018)CrossRef Kwon, H., Jung, E.-Y.: The impact of policy on the growth of precision medicine. Healthy Policy Technol. 7, 347–357 (2018)CrossRef
4.
Zurück zum Zitat Roukos, D.H.: Clinical cancer genome and precision medicine. Ann SurgOncol. 19(12), 3646–3650 (2012) Roukos, D.H.: Clinical cancer genome and precision medicine. Ann SurgOncol. 19(12), 3646–3650 (2012)
6.
Zurück zum Zitat Mesko, B.: The role of artificial intelligence in precision medicine. Expert Rev. Precis. Med. Drug Dev. 2(5), 239–241 (2017)CrossRef Mesko, B.: The role of artificial intelligence in precision medicine. Expert Rev. Precis. Med. Drug Dev. 2(5), 239–241 (2017)CrossRef
7.
Zurück zum Zitat Knowles, L.: Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. J. Law Biosci. 4, 453–506 (2017)CrossRef Knowles, L.: Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. J. Law Biosci. 4, 453–506 (2017)CrossRef
8.
Zurück zum Zitat Awwalu, J., Garba, A.G., Ghazvini, A., Atuah, R.: Artificial intelligence in personalized medicine application of ai algorithms in solving personalized medicine problems. Int. J. Comput. Theory Eng. 7(6), 439–443 (2015)CrossRef Awwalu, J., Garba, A.G., Ghazvini, A., Atuah, R.: Artificial intelligence in personalized medicine application of ai algorithms in solving personalized medicine problems. Int. J. Comput. Theory Eng. 7(6), 439–443 (2015)CrossRef
9.
Zurück zum Zitat Williams, A.M., Liu, Y., Regner, K.R., Jotterand, F., Liu, P., Liang, M.: Artificial intelligence, physiological genomics, and precision medicine. Physiol. Genom. 50(4), 237–243 (2018)CrossRef Williams, A.M., Liu, Y., Regner, K.R., Jotterand, F., Liu, P., Liang, M.: Artificial intelligence, physiological genomics, and precision medicine. Physiol. Genom. 50(4), 237–243 (2018)CrossRef
10.
Zurück zum Zitat Barker, R.W.: Is precision medicine the future of healthcare? Pers. Med. 14(6), 459–461 (2017)CrossRef Barker, R.W.: Is precision medicine the future of healthcare? Pers. Med. 14(6), 459–461 (2017)CrossRef
11.
Zurück zum Zitat Bartlett, G., Rahimzadeh, V., Longo, C., Orlando, L.A., Dawes, M., Lachaine, J., Bochud, M., Paccaud, F., Bergman, H., Crimi, L., Issa, A.M.: The future of genomic testing in primary care: the changing face of personalized medicine. Pers. Med. 11, 477–486 (2014)CrossRef Bartlett, G., Rahimzadeh, V., Longo, C., Orlando, L.A., Dawes, M., Lachaine, J., Bochud, M., Paccaud, F., Bergman, H., Crimi, L., Issa, A.M.: The future of genomic testing in primary care: the changing face of personalized medicine. Pers. Med. 11, 477–486 (2014)CrossRef
13.
Zurück zum Zitat Chang, L.-C., Colonna, T.E.: Recent updates and challenges on the regulation of precision medicine: the United States in perspective. Regul. Toxicol. Pharmacol. 96, 41–47 (2018)CrossRef Chang, L.-C., Colonna, T.E.: Recent updates and challenges on the regulation of precision medicine: the United States in perspective. Regul. Toxicol. Pharmacol. 96, 41–47 (2018)CrossRef
14.
Zurück zum Zitat Conti, R., Veenstra, D.L., Armstrong, K., Lesko, L.J., Grosse, S.D.: Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med. Decis. Making 30(3), 328–340 (2010)CrossRef Conti, R., Veenstra, D.L., Armstrong, K., Lesko, L.J., Grosse, S.D.: Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med. Decis. Making 30(3), 328–340 (2010)CrossRef
15.
Zurück zum Zitat Gray, M., Meehan, J., Ward, C., Langdon, S.P., Kunkler, I.H., Murray, A., Argyle, D.: Implantable biosensors and their contribution to the future of precision medicine. Vet. J. 239, 21–29 (2018)CrossRef Gray, M., Meehan, J., Ward, C., Langdon, S.P., Kunkler, I.H., Murray, A., Argyle, D.: Implantable biosensors and their contribution to the future of precision medicine. Vet. J. 239, 21–29 (2018)CrossRef
16.
Zurück zum Zitat Malod-Dognin, N., Petschnigg, J., Pržulj, N.: Precision medicine - a promising, yet challenging road lies ahead. Curr. Opin. Syst. Biol. 7, 1–7 (2018)CrossRef Malod-Dognin, N., Petschnigg, J., Pržulj, N.: Precision medicine - a promising, yet challenging road lies ahead. Curr. Opin. Syst. Biol. 7, 1–7 (2018)CrossRef
17.
Zurück zum Zitat Korngiebel, D.M., Thummel, K.E., Burke, W.: Implementing precision medicine: the ethical challenges. Trends Pharmacol. Sci. 38(1), 8–14 (2017)CrossRef Korngiebel, D.M., Thummel, K.E., Burke, W.: Implementing precision medicine: the ethical challenges. Trends Pharmacol. Sci. 38(1), 8–14 (2017)CrossRef
18.
Zurück zum Zitat Love-Koh, J., Peel, A., Rejon-Parilla, J.C., Ennis, K., Lovett, R., Manca, A., Taylor, M.: The future of precision medicine: potential impacts for health technology assessment. PharmacoEconomics 36, 1439–1451 (2018)CrossRef Love-Koh, J., Peel, A., Rejon-Parilla, J.C., Ennis, K., Lovett, R., Manca, A., Taylor, M.: The future of precision medicine: potential impacts for health technology assessment. PharmacoEconomics 36, 1439–1451 (2018)CrossRef
Metadaten
Titel
Precision Medicine: A Personalized Treatment from Your Gene
verfasst von
P. K. Balasubramani
K. Preetha
M. Aswanth Harish
Copyright-Jahr
2019
DOI
https://doi.org/10.1007/978-3-030-25135-2_2

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.